CSI Market
Sign In | Register

Sab Biotherapeutics Inc (SABS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SABS Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Sab Biotherapeutics Inc's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent8.27
Short-term Investments, Total0.00
Cash & Short-term Investments8.00
Accrued Investment Income Receivable AC1.84
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.46
Total Current Assets107.94
Equipment/Property/Plant Net32.98
Long-term investments105.35
Deferred Finance Costs, Net DE10.00
Other Assets, Noncurrent86.31
Operating Lease Right Of Use Asset2.89
Finance Lease Right Of Use Asset3.47
Total Assets238.21
Liabilities
Accounts Payable, Current AC3.86
Accrued Liabilities, Current AC4.30
Other Liabilities, Current3.55
Total Current Liabilities11.71
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE7.23
Other liabilities, Noncurrent4.49
Operating Lease Liability Current0.76
Finance Lease Liability Current0.16
Operating Lease Liability Noncurrent2.17
Finance Lease Liability Noncurrent3.08
Total Liabilities23.43
Stockholders' Equity
Common Stock Value0.01
Treasury Stock Value-5.52
Additional Paid In Capital Common Stock373.48
Retained Earnings / Accumulated Deficit-152.26
Accumulated Other Comprehensive Income-0.93
Other Equity-0.93
Common Stockholder's Equity214.79
Preferred Stockholder's Equity0.00
Total Stockholder's Equity214.79
Liabilities & Stockholder's Equity238.21
4 historic quarters locked

Sign in to unlock the full Sab Biotherapeutics Inc balance sheet history.

Sign In Create Free Account

About Sab Biotherapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-336783

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.